Version 2.80

Description

Zanamivir (INN) is a neuraminidase inhibitor used in the treatment and prophylaxis of Influenzavirus A and Influenzavirus B. Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithKline under the trade name Relenza. According to the Centers for Disease Control and Prevention (CDC), no flu, seasonal or pandemic, has shown any signs of resistance to zanamivir. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia , wikipedia

Basic Part Properties

Part Name
Zanamivir
Part Display Name
Zanamivir
Part Type
Component (Describes the core component or analyte measured)
Created On
2010-07-22
Construct for LOINC Short Name
Zanamivir

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP101309-5
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP101309-5

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 扎那米韦
Synonyms: 瑞乐沙
ru-RU Russian (Russian Federation) Занамивир
it-IT Italian (Italy) Zanamivir
es-ES Spanish (Spain) Zanamivir
fr-CA French (Canada) Zanamivir
tr-TR Turkish (Turkey) Zanamivir
nl-NL Dutch (Netherlands) Zanamivir
el-GR Greek (Greece) Ζαναμιβίρη
Synonyms: Ζαναμιβίρη